Reviews - 1n6j mentioned but not cited (2)
- Structural Basis for Plant MADS Transcription Factor Oligomerization. Lai X, Daher H, Galien A, Hugouvieux V, Zubieta C. Comput Struct Biotechnol J 17 946-953 (2019)
- A Review of Calcineurin Biophysics with Implications for Cardiac Physiology. Williams RB, Johnson CN. Int J Mol Sci 22 11565 (2021)
Articles - 1n6j mentioned but not cited (13)
- MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma. Ying CY, Dominguez-Sola D, Fabi M, Lorenz IC, Hussein S, Bansal M, Califano A, Pasqualucci L, Basso K, Dalla-Favera R. Nat Immunol 14 1084-1092 (2013)
- phenix.model_vs_data: a high-level tool for the calculation of crystallographic model and data statistics. Afonine PV, Grosse-Kunstleve RW, Chen VB, Headd JJ, Moriarty NW, Richardson JS, Richardson DC, Urzhumtsev A, Zwart PH, Adams PD. J Appl Crystallogr 43 669-676 (2010)
- Sequence motifs in MADS transcription factors responsible for specificity and diversification of protein-protein interaction. van Dijk AD, Morabito G, Fiers M, van Ham RC, Angenent GC, Immink RG. PLoS Comput Biol 6 e1001017 (2010)
- Landscape of DNA binding signatures of myocyte enhancer factor-2B reveals a unique interplay of base and shape readout. Dantas Machado AC, Cooper BH, Lei X, Di Felice R, Chen L, Rohs R. Nucleic Acids Res 48 8529-8544 (2020)
- Correlated mutations via regularized multinomial regression. Sreekumar J, ter Braak CJ, van Ham RC, van Dijk AD. BMC Bioinformatics 12 444 (2011)
- Template-based structure prediction and classification of transcription factors in Arabidopsis thaliana. Lu T, Yang Y, Yao B, Liu S, Zhou Y, Zhang C. Protein Sci 21 828-838 (2012)
- Conserved and variable correlated mutations in the plant MADS protein network. van Dijk AD, van Ham RC. BMC Genomics 11 607 (2010)
- Overexpression of the AGL42 gene in cotton delayed leaf senescence through downregulation of NAC transcription factors. Latif A, Azam S, Shahid N, Javed MR, Haider Z, Yasmeen A, Sadaqat S, Shad M, Husnain T, Rao AQ. Sci Rep 12 21093 (2022)
- The dipeptidyl peptidase IV inhibitors vildagliptin and K-579 inhibit a phospholipase C: a case of promiscuous scaffolds in proteins. Chakraborty S, Rendón-Ramírez A, Ásgeirsson B, Dutta M, Ghosh AS, Oda M, Venkatramani R, Rao BJ, Dandekar AM, Goñi FM. F1000Res 2 286 (2013)
- Crystal Structures of Ternary Complexes of MEF2 and NKX2-5 Bound to DNA Reveal a Disease Related Protein-Protein Interaction Interface. Lei X, Zhao J, Sagendorf JM, Rajashekar N, Xu J, Dantas Machado AC, Sen C, Rohs R, Feng P, Chen L. J Mol Biol 432 5499-5508 (2020)
- Preparing a database of corrected protein structures important in cell signaling pathways. Hatami S, Sirous H, Mahnam K, Najafipour A, Fassihi A. Res Pharm Sci 18 67-77 (2023)
- Molecular modeling and expression analysis of a MADS-box cDNA from mango (Mangifera indica L.). Pacheco-Sánchez MA, Contreras-Vergara CA, Hernandez-Navarro E, Yepiz-Plascencia G, Martínez-Téllez MA, Casas-Flores S, Arvizu-Flores AA, Islas-Osuna MA. 3 Biotech 4 357-365 (2014)
- Physicochemical models of protein-DNA binding with standard and modified base pairs. Chiu TP, Rao S, Rohs R. Proc Natl Acad Sci U S A 120 e2205796120 (2023)
Reviews citing this publication (17)
- Control of cardiac growth by histone acetylation/deacetylation. Backs J, Olson EN. Circ Res 98 15-24 (2006)
- Class II histone deacetylases: from sequence to function, regulation, and clinical implication. Yang XJ, Grégoire S. Mol Cell Biol 25 2873-2884 (2005)
- Toward transcriptional therapies for the failing heart: chemical screens to modulate genes. McKinsey TA, Olson EN. J Clin Invest 115 538-546 (2005)
- Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface. McKinsey TA, Kass DA. Nat Rev Drug Discov 6 617-635 (2007)
- Cardiac histone acetylation--therapeutic opportunities abound. McKinsey TA, Olson EN. Trends Genet 20 206-213 (2004)
- MEF2 transcription factors: developmental regulators and emerging cancer genes. Pon JR, Marra MA. Oncotarget 7 2297-2312 (2016)
- HDAC-dependent ventricular remodeling. Xie M, Hill JA. Trends Cardiovasc Med 23 229-235 (2013)
- Targeting inflammation in heart failure with histone deacetylase inhibitors. McKinsey TA. Mol Med 17 434-441 (2011)
- From genetics to the clinic: a translational perspective on follicular lymphoma. Huet S, Sujobert P, Salles G. Nat Rev Cancer 18 224-239 (2018)
- Calcineurin signaling in the heart: The importance of time and place. Parra V, Rothermel BA. J Mol Cell Cardiol 103 121-136 (2017)
- Role of calcineurin in striated muscle: development, adaptation, and disease. Bassel-Duby R, Olson EN. Biochem Biophys Res Commun 311 1133-1141 (2003)
- Calmodulin-dependent phosphatase, kinases, and transcriptional corepressors involved in T-cell activation. Liu JO. Immunol Rev 228 184-198 (2009)
- Targeting histone deacetylases for heart failure. Bush EW, McKinsey TA. Expert Opin Ther Targets 13 767-784 (2009)
- Myocyte enhancer factor 2C and its directly-interacting proteins: A review. Dong C, Yang XZ, Zhang CY, Liu YY, Zhou RB, Cheng QD, Yan EK, Yin DC. Prog Biophys Mol Biol 126 22-30 (2017)
- A Molecular Prospective for HIRA Complex Assembly and H3.3-Specific Histone Chaperone Function. Ricketts MD, Marmorstein R. J Mol Biol 429 1924-1933 (2017)
- Involvement of myocyte enhancer factor 2c in the pathogenesis of autism spectrum disorder. Chaudhary R, Agarwal V, Kaushik AS, Rehman M. Heliyon 7 e06854 (2021)
- Cracking the Floral Quartet Code: How Do Multimers of MIKCC-Type MADS-Domain Transcription Factors Recognize Their Target Genes? Käppel S, Rümpler F, Theißen G. Int J Mol Sci 24 8253 (2023)
Articles citing this publication (44)
- Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Kong Y, Tannous P, Lu G, Berenji K, Rothermel BA, Olson EN, Hill JA. Circulation 113 2579-2588 (2006)
- SOC1 translocated to the nucleus by interaction with AGL24 directly regulates leafy. Lee J, Oh M, Park H, Lee I. Plant J 55 832-843 (2008)
- MOSAIC FLORAL ORGANS1, an AGL6-like MADS box gene, regulates floral organ identity and meristem fate in rice. Ohmori S, Kimizu M, Sugita M, Miyao A, Hirochika H, Uchida E, Nagato Y, Yoshida H. Plant Cell 21 3008-3025 (2009)
- CREB binds to multiple loci on human chromosome 22. Euskirchen G, Royce TE, Bertone P, Martone R, Rinn JL, Nelson FK, Sayward F, Luscombe NM, Miller P, Gerstein M, Weissman S, Snyder M. Mol Cell Biol 24 3804-3814 (2004)
- TGF-beta-activated Smad3 represses MEF2-dependent transcription in myogenic differentiation. Liu D, Kang JS, Derynck R. EMBO J 23 1557-1566 (2004)
- Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma. Assouline SE, Nielsen TH, Yu S, Alcaide M, Chong L, MacDonald D, Tosikyan A, Kukreti V, Kezouh A, Petrogiannis-Haliotis T, Albuquerque M, Fornika D, Alamouti S, Froment R, Greenwood CM, Oros KK, Camglioglu E, Sharma A, Christodoulopoulos R, Rousseau C, Johnson N, Crump M, Morin RD, Mann KK. Blood 128 185-194 (2016)
- Mechanism of recruitment of class II histone deacetylases by myocyte enhancer factor-2. Han A, He J, Wu Y, Liu JO, Chen L. J Mol Biol 345 91-102 (2005)
- On the origin of MADS-domain transcription factors. Gramzow L, Ritz MS, Theissen G. Trends Genet 26 149-153 (2010)
- Human CABIN1 is a functional member of the human HIRA/UBN1/ASF1a histone H3.3 chaperone complex. Rai TS, Puri A, McBryan T, Hoffman J, Tang Y, Pchelintsev NA, van Tuyn J, Marmorstein R, Schultz DC, Adams PD. Mol Cell Biol 31 4107-4118 (2011)
- The CRM1 nuclear export receptor controls pathological cardiac gene expression. Harrison BC, Roberts CR, Hood DB, Sweeney M, Gould JM, Bush EW, McKinsey TA. Mol Cell Biol 24 10636-10649 (2004)
- Alternative pre-mRNA splicing governs expression of a conserved acidic transactivation domain in myocyte enhancer factor 2 factors of striated muscle and brain. Zhu B, Ramachandran B, Gulick T. J Biol Chem 280 28749-28760 (2005)
- Genome-wide identification and analysis of the MADS-box gene family in apple. Tian Y, Dong Q, Ji Z, Chi F, Cong P, Zhou Z. Gene 555 277-290 (2015)
- Crystal structure of a conserved N-terminal domain of histone deacetylase 4 reveals functional insights into glutamine-rich domains. Guo L, Han A, Bates DL, Cao J, Chen L. Proc Natl Acad Sci U S A 104 4297-4302 (2007)
- Phosphorylation-facilitated sumoylation of MEF2C negatively regulates its transcriptional activity. Kang J, Gocke CB, Yu H. BMC Biochem 7 5 (2006)
- Feedback inhibition of calcineurin and Ras by a dual inhibitory protein Carabin. Pan F, Sun L, Kardian DB, Whartenby KA, Pardoll DM, Liu JO. Nature 445 433-436 (2007)
- superwoman1-cleistogamy, a hopeful allele for gene containment in GM rice. Yoshida H, Itoh J, Ohmori S, Miyoshi K, Horigome A, Uchida E, Kimizu M, Matsumura Y, Kusaba M, Satoh H, Nagato Y. Plant Biotechnol J 5 835-846 (2007)
- MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis. Brescia P, Schneider C, Holmes AB, Shen Q, Hussein S, Pasqualucci L, Basso K, Dalla-Favera R. Cancer Cell 34 453-465.e9 (2018)
- Caffeine induces hyperacetylation of histones at the MEF2 site on the Glut4 promoter and increases MEF2A binding to the site via a CaMK-dependent mechanism. Mukwevho E, Mukwevho E, Kohn TA, Lang D, Nyatia E, Smith J, Ojuka EO. Am J Physiol Endocrinol Metab 294 E582-8 (2008)
- S-nitrosylation-mediated redox transcriptional switch modulates neurogenesis and neuronal cell death. Okamoto S, Nakamura T, Cieplak P, Chan SF, Kalashnikova E, Liao L, Saleem S, Han X, Clemente A, Nutter A, Sances S, Brechtel C, Haus D, Haun F, Sanz-Blasco S, Huang X, Li H, Zaremba JD, Cui J, Gu Z, Nikzad R, Harrop A, McKercher SR, Godzik A, Yates JR, Lipton SA. Cell Rep 8 217-228 (2014)
- Structure of p300 bound to MEF2 on DNA reveals a mechanism of enhanceosome assembly. He J, Ye J, Cai Y, Riquelme C, Liu JO, Liu X, Han A, Chen L. Nucleic Acids Res 39 4464-4474 (2011)
- HPC2 and ubinuclein define a novel family of histone chaperones conserved throughout eukaryotes. Balaji S, Iyer LM, Aravind L. Mol Biosyst 5 269-275 (2009)
- SUMO-1 modification of MEF2A regulates its transcriptional activity. Riquelme C, Barthel KK, Liu X. J Cell Mol Med 10 132-144 (2006)
- The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressiveness. Di Giorgio E, Franforte E, Cefalù S, Rossi S, Dei Tos AP, Brenca M, Polano M, Maestro R, Paluvai H, Picco R, Brancolini C. PLoS Genet 13 e1006752 (2017)
- Inhibition of the function of class IIa HDACs by blocking their interaction with MEF2. Jayathilaka N, Han A, Gaffney KJ, Dey R, Jarusiewicz JA, Noridomi K, Philips MA, Lei X, He J, Ye J, Gao T, Petasis NA, Chen L. Nucleic Acids Res 40 5378-5388 (2012)
- Salt-inducible kinase inhibition suppresses acute myeloid leukemia progression in vivo. Tarumoto Y, Lin S, Wang J, Milazzo JP, Xu Y, Lu B, Yang Z, Wei Y, Polyanskaya S, Wunderlich M, Gray NS, Stegmaier K, Vakoc CR. Blood 135 56-70 (2020)
- Myocyte enhancer factor 2A is transcriptionally autoregulated. Ramachandran B, Yu G, Li S, Zhu B, Gulick T. J Biol Chem 283 10318-10329 (2008)
- Structure of the MADS-box/MEF2 domain of MEF2A bound to DNA and its implication for myocardin recruitment. Wu Y, Dey R, Han A, Jayathilaka N, Philips M, Ye J, Chen L. J Mol Biol 397 520-533 (2010)
- Functional analysis of the Mad1-mSin3A repressor-corepressor interaction reveals determinants of specificity, affinity, and transcriptional response. Cowley SM, Kang RS, Frangioni JV, Yada JJ, DeGrand AM, Radhakrishnan I, Eisenman RN. Mol Cell Biol 24 2698-2709 (2004)
- Identification of genetic aberrations on chromosome 22 outside the NF2 locus in schwannomatosis and neurofibromatosis type 2. Buckley PG, Mantripragada KK, Díaz de Ståhl T, Piotrowski A, Hansson CM, Kiss H, Vetrie D, Ernberg IT, Nordenskjöld M, Bolund L, Sainio M, Rouleau GA, Niimura M, Wallace AJ, Evans DG, Grigelionis G, Menzel U, Dumanski JP. Hum Mutat 26 540-549 (2005)
- Reversal of pathological cardiac hypertrophy via the MEF2-coregulator interface. Wei J, Joshi S, Speransky S, Crowley C, Jayathilaka N, Lei X, Wu Y, Gai D, Jain S, Hoosien M, Gao Y, Chen L, Bishopric NH. JCI Insight 2 91068 (2017)
- Cabin1 expression suggests roles in neuronal development. Hammond DR, Udvadia AJ. Dev Dyn 239 2443-2451 (2010)
- Truncated HDAC9 identified by integrated genome-wide screen as the key modulator for paclitaxel resistance in triple-negative breast cancer. Lian B, Pei YC, Jiang YZ, Xue MZ, Li DQ, Li XG, Zheng YZ, Liu XY, Qiao F, Sun WL, Ling H, He M, Yao L, Hu X, Shao ZM. Theranostics 10 11092-11109 (2020)
- Myocyte enhancer factor (MEF)-2 plays essential roles in T-cell transformation associated with HTLV-1 infection by stabilizing complex between Tax and CREB. Jain P, Lavorgna A, Sehgal M, Gao L, Ginwala R, Sagar D, Harhaj EW, Khan ZK. Retrovirology 12 23 (2015)
- Myocyte enhancer factor 2 activates promoter sequences of the human AbetaH-J-J locus, encoding aspartyl-beta-hydroxylase, junctin, and junctate. Feriotto G, Finotti A, Volpe P, Treves S, Ferrari S, Angelelli C, Zorzato F, Gambari R. Mol Cell Biol 25 3261-3275 (2005)
- BCL6--regulated by AhR/ARNT and wild-type MEF2B--drives expression of germinal center markers MYBL1 and LMO2. Ding J, Dirks WG, Ehrentraut S, Geffers R, MacLeod RA, Nagel S, Pommerenke C, Romani J, Scherr M, Vaas LA, Zaborski M, Drexler HG, Quentmeier H. Haematologica 100 801-809 (2015)
- MEF2C DNA-binding activity is inhibited through its interaction with the regulatory protein Ki-1/57. Kobarg CB, Kobarg J, Crosara-Alberto DP, Theizen TH, Franchini KG. FEBS Lett 579 2615-2622 (2005)
- Meta-coexpression conservation analysis of microarray data: a "subset" approach provides insight into brain-derived neurotrophic factor regulation. Aid-Pavlidis T, Pavlidis P, Timmusk T. BMC Genomics 10 420 (2009)
- Pattern of MEF2B expression in lymphoid tissues and in malignant lymphomas. Krenács D, Borbényi Z, Bedekovics J, Méhes G, Bagdi E, Krenács L. Virchows Arch 467 345-355 (2015)
- Overexpression of MEF2D contributes to oncogenic malignancy and chemotherapeutic resistance in ovarian carcinoma. Li X, Zhang Y, Chai X, Zhou S, Zhang H, He J, Zhou R, Cai L, Chen L, Tao G. Am J Cancer Res 9 887-905 (2019)
- The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways. Magistri M, Happ LE, Ramdial J, Lu X, Stathias V, Kunkalla K, Agarwal N, Jiang X, Schürer SC, Dubovy SR, Chapman JR, Vega F, Dave S, Lossos IS. Cancer Res Commun 1 1-16 (2021)
- Transcriptomic and genomic studies classify NKL54 as a histone deacetylase inhibitor with indirect influence on MEF2-dependent transcription. Minisini M, Di Giorgio E, Kerschbamer E, Dalla E, Faggiani M, Franforte E, Meyer-Almes FJ, Ragno R, Antonini L, Mai A, Fiorentino F, Fiorentino F, Rotili D, Chinellato M, Perin S, Cendron L, Weichenberger CX, Angelini A, Brancolini C. Nucleic Acids Res 50 2566-2586 (2022)
- A Model for Dimerization of the SOX Group E Transcription Factor Family. Ramsook SN, Ni J, Shahangian S, Vakiloroayaei A, Khan N, Kwan JJ, Donaldson LW. PLoS One 11 e0161432 (2016)
- Angiotensin II Mediates Cardiomyocyte Hypertrophy in Atrial Cardiomyopathy via Epigenetic Transcriptional Regulation. Zheng L, Wang J, Zhang R, Zhang Y, Geng J, Cao L, Zhao X, Geng J, Du X, Hu Y, Cong H. Comput Math Methods Med 2022 6312100 (2022)
- The cleistogamy of the superwoman1-cleistogamy1 mutation is sensitive to low temperatures during the lodicule-forming stage. Ohmori S, Koike S, Hayashi T, Yamaguchi T, Kuroki M, Yoshida H. Breed Sci 68 432-441 (2018)